Genetic determinants influencing the response to injury, inflammation, and sepsis

Shock

Volumn 23, Issue 1, 2005, Pages 11-17

  De Maio, Antonio ^a   Torres, Manuel B ^a   Reeves, Roger H ^a  

^a JOHNS HOPKINS UNIVERSITY SCHOOL OF MEDICINE   (United States)

Author keywords

Aging; Genetics; Inflammation; Injury; Sepsis; Sex

Indexed keywords

BACTERIUM LIPOPOLYSACCHARIDE;

AGE; CRITICAL ILLNESS; DIETARY INTAKE; DISEASE COURSE; DISEASE MODEL; DISEASE PREDISPOSITION; GENDER; GENE LOCUS; GENE MAPPING; GENETIC ASSOCIATION; GENETIC RISK; GENETIC VARIABILITY; HUMAN; INFLAMMATION; INJURY; LIGATION; MOLECULAR CLONING; MOUSE; MOUSE STRAIN; NONHUMAN; REVIEW; SEPSIS;

AGE FACTORS; ANIMALS; ESCHERICHIA COLI; GENETIC PREDISPOSITION TO DISEASE; HUMANS; INFLAMMATION; INTERLEUKIN-10; LIPOPOLYSACCHARIDES; MICE; MICE, INBRED STRAINS; RECOMBINANT PROTEINS; SEPSIS; SEX FACTORS; TIME FACTORS; VARIATION (GENETICS);

EID: 11844267259     PISSN: 10732322     EISSN: None     Source Type: Journal    
DOI: 10.1097/01.shk.0000144134.03598.c5     Document Type: Review

References (89)

1. Baue AE: MOF/MODS, SIRS: An update. Shock 6: S1-S5, 1996.
2. Meakins JL: Etiology of multiple organ failure. J Trauma 30:S165-S168, 1990.
3. Angus DC, Wax RS: Epidemiology of sepsis: An update. Crit Care Med 29:S109-S116, 2001.
4. Livingston DH, Mosenthal AC, Deitch EA: Sepsis and multiple organ dysfunction syndrome: A clinical-mechanistic overview. New Horiz 3:257-266, 1995.
5. Pruitt JH, Copeland EM, Moldawer LL: Interleukin-1 and interleukin-1 antagonism in sepsis systemic inflammatory response syndrome, and septic shock. Shock 3:235-251, 1995.
6. Williams G, Giroir B: Regulation of cytokine gene expression: tumor necrosis factor, interleukin-1, and the emerging biology of cytokine receptors. New Horiz 3:276-287, 1995.
7. De Maio A, Mooney ML, Matesic LE, Paidas CN, Reeves RH: Genetic component in the inflammatory response induced by bacterial lipopolysaccharide. Shock 10:319-323, 1998.
8. Rinderknecht H: Genetic determinants of mortality in acute necrotizing pancreatitis. Int J Pancreatol 16:11-16, 1994.
9. Jacob CO, Hwang F, Lewis GD, Stall AM: Tumor necrosis factor alpha in murine systemic lupus erythematosus disease models: implications for genetic predisposition and immune regulation. Cytokine 3:551-561, 1991.
10. McGuire W, Hill AV, Allsopp CE, Greenwood BM, Kwiatkowski D: Variation in the TNF-alpha promoter region associated with susceptibility to cerebral malaria. Nature 371:508-510, 1994.
11. Stuber F, Petersen M, Bokelmann F, Schade U: A genomic polymorphism within the tumor necrosis factor locus influences plasma tumor necrosis factor-alpha concentrations and outcome of patients with severe sepsis. Crit Care Med 24:381-384, 1996.
12. Saleh M, Vaillancourt JP, Graham RK, Huyck M, Srinivasula SM, Alnemri ES, Steinberg MH, Nolan V, Baldwin CT, Hotchkiss RS, Buchman TG, Zehnbauer BA, Hayden MR, Farrer LA, Roy S, Nicholson DW: Differential modulation of endotoxin responsiveness by human caspase-12 polymorphisms. Nature 429:75-79, 2004.
13. Garred P, Strom JJ, Quist L, Taaning E, Madsen HO: Association of mannose-binding lectin polymorphisms with sepsis and fatal outcome, in patients with systemic inflammatory response syndrome. J Infect Dis 188:1394-1403, 2003.
14. Schroeder S, Reck M, Hoeft A, Stuber F: Analysis of two human leukocyte antigen-linked polymorphic heat shock protein 70 genes in patients with severe sepsis. Crit Care Med 27:1265-1270, 1999.
15. Hubacek JA, Stuber F, Frohlich D, Book M, Wetegrove S, Rothe G, Schmitz G: The common functional C(-159)T polymorphism within the promoter region of the lipopolysaccharide receptor CD14 is not associated with sepsis development or mortality. Genes Immun 1:405-407, 2000.
16. Gibot S, Cariou A, Drouet L, Rossignol M, Ripoll L: Association between a genomic polymorphism within the CD 14 locus and septic shock susceptibility and mortality rate. Crit Care Med 30:969-973, 2002.
17. Lorenz E, Mira JP, Frees KL, Schwartz DA: Relevance of mutations in the TLR4 receptor in patients with gram-negative septic shock. Arch Intern Med 162:1028-1032, 2002.
18. Schluter B, Raufhake C, Erren M, Schotte H, Kipp F, Rust S, Van Aken H, Assmann G, Berendes E: Effect of the interleukin-6 promoter polymorphism (-174 G/C) on the incidence and outcome of sepsis. Crit Care Med 30:32-37, 2002.
19. Holmes CL, Russell JA, Walley KR: Genetic polymorphisms in sepsis and septic shock: role in prognosis and potential for therapy. Chest 124:1103-1115, 2003.
20. Lin MT, Albertson TE: Genomic polymorphisms in sepsis. Crit Care Med 32:569-579, 2004.
21. Texereau J, Pene F, Chiche JD, Rousseau C, Mira JP: Importance of hemostatic gene polymorphisms for susceptibility to and outcome of severe sepsis. Crit Care Med 32:S313-S319, 2004.
22. O'Malley J, Matesic LE, Zink C, Strandberg JD, Mooney ML, De Maio A, Reeves RH: Comparison of acute endotoxin-induced lesions in A/J and C57BL/6J mice. J Hered 89:525-530, 1998.
23. Vega VL, de Cabo R, De Maio A: Age and caloric restriction diets are confounding factors that modify the response to LPS by peritoneal macrophages from C57BL/6 mice. Shock 22:248-253, 2004.
24. Stewart D, Fulton WB, Wilson C, Monitto CL, Paidas CN, Reeves RH, De Maio A: Genetic contribution to the septic response in a mouse model. Shock 18:342-347, 2002.
25. Remick DG, Newcomb DE, Bolgos GL, Call DR: Comparison of the mortality and inflammatory response of two models of sepsis: lipopolysaccharide versus cecal ligation and puncture. Shock 13:110-116, 2000.
26. Deitch EA, Ma L, Ma J-W, Berg RD: Lethal burn-induced bacterial translocation: Role of genetic resistance. J Trauma 29:1480-1487, 1989.
27. Vannier E, Borggraefe I, Telford SR 3rd, Menon S, Brauns T, Spielman A, Gelfand JA, Wortis HH: Age-associated decline in resistance to Babesia microti is genetically determined. J Infect Dis 189:1721-1728, 2004.
28. McKenna IM, Waalkes MP, Chen LC, Gordon T: Comparison of inflammatory lung responses in Wistar rats and C57 and DBA mice following acute exposure to cadmium oxide fumes. Toxicol Appl Pharmacol 146:196-206, 1997.
29. Radojicic C, Andric B, Simovic M, Dujic A, Marinkovic D: Genetic basis of resistance to trauma in inbred strains of mice. J Trauma 30:211-213, 1990.
30. Trentzsch H, Stewart D, Paidas CN, De Maio A: The combination of polymicrobial sepsis and endotoxin results in inflammatory process that could not be predicted based on the independent insults. J Surg Res 111:203-208, 2003.
31. Barrow RE, Herndon DN: Thermal burns, gender, and survival. Lancet 2:1076-1077, 1988.
32. American college of chest physicians/society of critical care medicine consensus conference: definitions for sepsis and organ failure and guidelines for the use of innovative therapies in sepsis. Crit Care Med 20:864-874, 1992.
33. Schroder J, Kahlke V, Book M, Stuber F: Gender differences in sepsis: genetically determined? Shock 14:307-310, 2000.
34. Schroder J, Kahlke V, Staubach KH, Zabel P, Stuber F: Gender differences in human sepsis. Arch Surg 133:1200-1205, 1998.
35. McLauchlan GJ, Anderson ID, Grant IS, Fearon KC: Outcome of patients with abdominal sepsis treated in an intensive care unit. Br J Surg 82:524-529, 1995.
36. Eachempati SR, Hydo L, Barie PS: Gender-based differences in outcome in patients with sepsis. Arch Surg 134:1342-1347, 1999.
37. Guidet B, Barakett V, Vassal T, Petit JC, Offenstadt G: Endotoxemia and bacteremia in patients with sepsis syndrome in the intensive care unit. Chest 106:1194-1201, 1994.
38. Riche F, Panis Y, Laisne MJ, Briard C, Cholley B, Bernard-Poenaru O, Graulet AM, Gueris J, Valleur P: High tumor necrosis factor serum level is associated with increased survival in patients with abdominal septic shock: a prospective study in 59 patients. Surgery 120:801-807, 1996.
39. Wichmann MW, Inthorn D, Andress HJ, Schildberg FW: Incidence and mortality of severe sepsis in surgical intensive care patients: the influence of patient gender on disease process and outcome. Intensive Care Med 26:167-172, 2000.
40. Aube H, Milan C, Blettery B: Risk factors for septic shock in the early management of bacteremia. Am J Med 93:283-288, 1992.
41. Borgdorff MW, Nagelkerke NJ, Dye C, Nunn P: Gender and tuberculosis: a comparison of prevalence surveys with notification data to explore sex differences in case detection. Int J Tuberc Lung Dis 4:123-132, 2000.
42. Holmes CB, Hausler H, Nunn P: A review of sex differences in the epidemiology of tuberculosis. Int J Tuberc Lung Dis 2:96-104, 1998.
43. McGowan JE Jr, Barnes MW, Finland M: Bacteremia at Boston City Hospital: Occurrence and mortality during 12 selected years (1935-1972), with special reference to hospital-acquired cases. J Infect Dis 132:316-335, 1975.
44. Offner PJ, Moore EE, Biffl WL: Male gender is a risk factor for major infections after surgery. Arch Surg 134:935-938, 1999.
45. Angele MK, Schwacha MG, Ayala A, Chaudry IH: Effect of gender and sex hormones on immune responses following shock. Shock 14:81-90, 2000.
46. Ayala A, Perrin MM, Ertel W, Chaudry IH: Differential effects of hemorrhage on Kupffer cells: decreased antigen presentation despite increased inflammatory cytokine (IL-1, IL-6 and TNF) release. Cytokine 4:66-75, 1992.
47. Remmers DE, Cioffi WG, Bland KI, Wang P, Angele MK, Chaudry IH: Testosterone: the crucial hormone responsible for depressing myocardial function in males after trauma-hemorrhage. Ann Surg 227:790-799, 1998.
48. Remmers DE, Wang P, Cioffi WG, Bland KI, Chaudry IH: Testosterone receptor blockade after trauma-hemorrhage improves cardiac and hepatic functions in males. Am J Physiol 273:H2919-H2925, 1997.
49. Wichmann MW, Angele MK, Ayala A, Cioffi WG, Chaudry IH: Flutamide: A novel agent for restoring the depressed cell-mediated immunity following soft-tissue trauma and hemorrhagic shock. Shock 8:242-248, 1997.
50. Zellweger R, Wichmann MW, Ayala A, Stein S, DeMaso CM, Chaudry IH: Females in proestrus state maintain splenic immune functions and tolerate sepsis better than males. Crit Care Med 25:106-110, 1997.
51. Laubach VE, Foley PL, Shockey KS, Tribble CG, Kron IL: Protective roles of nitric oxide and testosterone in endotoxemia: evidence from NOS-2-deficient mice. Am J Physiol 275:H2211-H2218, 1998.
52. Wichmann MW, Zellweger R, DeMaso CM, Ayala A, Chaudry IH: Enhanced immune responses in females, as opposed to decreased responses in males following haemorrhagic shock and resuscitation. Cytokine 8:853-863, 1996.
53. Angele MK, Knoferl MW, Schwacha MG, Ayala A, Cioffi WG, Bland KI, Chaudry IH: Sex steroids regulate pro- and anti-inflammatory cytokine release by macrophages after trauma-hemorrhage. Am Physiol 277:C35-C42, 1999.
54. Trentzsch H, Stewart D, De Maio A: Genetic background conditions the effect of sex-steroids on the inflammatory response during endotoxic shock. Crit Care Med 31:232-236, 2003.
55. Kenyon C: A conserved regulatory system for aging. Cell 105:165-168, 2001.
56. Turnbull IR, Wlzorek JJ, Osborne D, Hotchkiss RS, Coopersmith CM, Buchman TG: effects of age on mortality and antibiotic efficacy in cecal ligation and puncture. Shock 19:310-313, 2003.
57. Miller RA: The aging immune system: primer and prospectus. Science 273:70-74, 1996.
58. Effros RB: Ageing and the Immune System. Novartis Foundation Symp 235:130-139; discussion 139-145, 146-149, 2001.
59. Vollmar B, Pradarutti S, Nickels RM, Menger MD: Age-associated loss of immunomodulatory protection by granulocyte-colony stimulating factor in endotoxic rats. Shock 18:348-354, 2002.
60. Bruunsgaard H, Skinhoj P, Qvist J, Pedersen BK: Elderly humans show prolonged in vivo inflammatory activity during pneumococcal infections. J Infect Dis 2:551-554, 1999.
61. Baggio G: Occurrence of chronic diseases and their impact on physical disability over the whole spectrum of aging: from 65 to over 100 years of age. Z Gerontol Geriatr 32:420-424, 1999.
62. Ballou SP, Lozanski FB, Hodder S, Rzewnicki DL, Mion LC, Sipe JD, Ford AB, Kushner I: Quantitative and qualitative alterations of acute-phase proteins in healthy elderly persons. Age Ageing 3:224-230, 1996.
63. Golden TR, Hinerfeld DA, Melov S: Oxidative stress and aging: beyond correlation. Aging Cell 2:117-123, 2002.
64. Sambhara S, Kurichh A, Miranda R, James O, Underdown B, Klein M, Tartaglia J, Burt D: Severe impairment of primary but not memory responses to influenza viral antigens in aged mice: costimulation in vivo partially reverses impaired primary immune responses. Cell Immunol 210:1-4, 2001.
65. Hsu HC, Shi J, Yang P, Xu X, Dodd C, Matsuki Y, Zhang HG, Mountz JD: Activated CD8(+) T cells from aged mice exhibit decreased activation-induced cell death. Mech Ageing Dev 122:1663-1684, 2001.
66. Franceschi C, Valensin S, Bonafe M, Paolisso G, Yashin A, Monti D, De Benedictis G: The network and the remodeling theories of aging: historical background and new perspectives. Exp Gerontol 35:879-896, 2000.
67. Gon Y, Hashimoto S, Hayashi S, Koura T, Matsumoto K, H T: Lower serum concentrations of cytokines in elderly patients with pneumonia and the impaired production of cytokines by peripheral blood monocytes in the elderly. Clin Exp Immunol 1:120-126, 1996.
68. Spaulding CC, Walford RL, Effros RB: Calorie restriction inhibits the age-related dysregulation of the cytokines TNF-alpha and IL-6 in C3B10RF1 mice. Mech Ageing Dev 93:87-94, 1997.
69. Davila DR, Edwards CK, Arkins S, Simon J, Kelley KW: Interferomgamma- induced priming for secretion of superoxide anion and tumor necrosis factor-alpha declines in macrophages from aged rats. FASEB J 11:2906-2911, 1990.
70. Delpedro AD, Barjavel MJ, Mamdouh Z, Faure S, Bakouche O: Signal transduction in LPS-activated aged and young monocytes. J Interferon Cytokine Res 18:429-437, 1998.
71. Antonini JM, Roberts JR, Clarke RW, Yang HM, Barger MW, Ma JY, Weissman DN: Effect of age on respiratory defense mechanisms: pulmonary bacterial clearance in Fischer 344 rats after intratracheal instillation of Listeria monocytogenes. Chest 1:240-249, 2001.
72. Tasat DR, Mancuso R, O'Connor S, Molinari B: Age-dependent change in reactive oxygen species and nitric oxide generation by rat alveolar macrophages. Aging Cell 3:159-164, 2003.
73. Knook DL, Brouwer A: Kupffer cells and the acute phase response: The effect of aging. Immunol Invest 1-4:339-350, 1989.
74. Sun WB, Han BL, Peng ZM, Li K, Ji Q, Chen J, Wang HZ, Ma RL: Effect of aging on cytoskeleton system of Kupffer cell and its phagocytic capacity. World J Gastroenterol 1:77-79, 1998.
75. Videla LA, Tapia G, Fernandez V: Influence of aging on Kupffer cell respiratory activity in relation to particle phagocytosis and oxidative stress parameters in mouse liver. Redox Rep 3:155-159, 2001.
76. Renshaw M, Rockwell J, Engleman C, Gewirtz A, Katz J, Sambhara S: Cutting edge: impaired Toll-like receptor expression and function in aging. J Immunol 169:4697-4701, 2002.
77. Friedman G, Ben-Yehuda A, Dabach Y, Ben-Naim M, Hollander G, Retter O, Friedlander Y, Stein O, Stein Y: Scavenger receptor activity and expression of apolipoprotein E mRNA in monocyte-derived macrophages of young and old healthy men. Atherosclerosis 1:67-73, 1997.
78. Ashcroft GS, Horan MA, Ferguson MW: Aging alters the inflammatory and endothelial cell adhesion molecule profiles during human cutaneous wound healing. Lab Invest 1:47-58, 1998.
79. Lavrovsky Y, Chatterjee B, Clark RA, Roy AK: Role of redox-regulated transcription factors in inflammation, aging and age-related diseases. Exp Gerontol 5:521-532, 2000.
80. Korstanje R, Paigen B: From QTL to gene: the harvest begins. Nat Genet 31:235-236, 2002.
81. Abiola O, Angel JM, Avner P, Bachmanov AA, Belknap JK, Bennett B, Blankenhorn EP, Blizard DA, Bolivar V, Brockmann GA, Buck KJ, Bureau JF, Casley WL, Chesler EJ, Cheverud JM, Churchill GA, Cook M, Crabbe JC, Crusio WE, Darvasi A, de Haan G, Dermant P, Doerge RW, Elliot RW, Farber CR, Flaherty L, Flint J, Gershenfeld H, Gibson JP, Gu J, Gu W, Himmelbauer H, Hitzemann R, Hsu HC, Hunter K, Iraqi FF, Jansen RC, Johnson TE, Jones BC, Kempermann G, Lammert F, Lu L, Manly KF, Matthews DB, Medrano JF, Mehrabian M, Mittlemann G, Mock BA, Mogil JS, Montagutelli X, Morahan G, Mountz JD, Nagase H, Nowakowski RS, O'Hara BF, Osadchuk AV, Paigen B, Palmer AA, Peirce JL, Pomp D, Rosemann M, Rosen GD, Schalkwyk LC, Seltzer Z, Settle S, Shimomura K, Shou S, Sikela JM, Siracusa LD, Spearow JL, Teuscher C, Threadgill DW, Toth LA, Toye AA, Vadasz C, Van Zant G, Wakeland E, Williams RW, Zhang HG, Zou F: The nature and identification of quantitative trait loci: a community's view. Nature Rev Genet 4:911-916, 2003.
82. Hu J, Bumstead N, Skamene E, Gros P, Malo D: Structural organization, sequence, and expression of the chicken NRAMP1 gene encoding the natural resistance-associated macrophage protein 1. DNA Cell Biol 15:113-123, 1996.
83. Qureshi ST, Lariviere L, Sebastiani G, Clermont S, Skamene E, Gros P, Malo D: A high-resolution map in the chromosomal region surrounding the Lps locus. Genomics 31:283-294, 1996.
84. Poltorak A, He X, Smirnova I, Liu M-Y, Van Huffel C, Du X, Birdwell D, Alejos E, Silva M, Galanos C, Freudenberg M, Ricciardi-Castagnoli P, Layton B, Beutler B: Defective LPS signaling in C3H/HeJ and C57BL/10ScCr mice: mutations in Tlr4 gene. Science 282:2085-2088, 1998.
85. Lemaitre B, Nicolas E, Michaut L, Reichhart JM, Hoffmann JA: The dorsoventral regulatory gene cassette spatzle/Toll/cactus controls the potent antifungal response in Drosophila adults. Cell 86:973-983, 1996.
86. Kuhns DB, Long Priel DA, Gallin JI: Endotoxin and IL-1 hyporesponsiveness in a patient with recurrent bacterial infections. J Immunol 158:3959-3964, 1997.
87. Reeves RH, D'Eustachio P: Genetic and comparative mapping in mouse. In Birren B, Green E, Hieter P, Meyers R (eds.). Genome Analysis: A Laboratory Manual. Cold Spring Harbor: Cold Spring Harbor Laboratory Press, 1997, pp 71-133.
88. Matesic LE, De Maio A, Reeves RH: Mapping lipopolysaccharide response loci in mice using recombinant inbred and congenic strains. Genomics 62:34-41, 1999.
89. Matesic LE, Niemitz EL, De Maio A, Reeves RH: Quantitative trait loci modulate neutrophil infiltration in the liver during LPS-induced inflammation. FASEB J 14:2247-2254, 2000.